Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry
MUSCULOSKELETAL CARE(2022)
摘要
Luis Cea-Calvo, is employed by MSD España, Madrid, Spain. The rest of the authors declared no conflicts of interest. The data base used for this study is not publicly available. If you need additional information, please address the corresponding author.
更多查看译文
关键词
axial spondylarthritis, golimumab, medication retention rate, psoriatic arthritis, rheumatoid arthritis
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要